Tuesday, March 21, 2023 | Back issues
Courthouse News Service Courthouse News Service


WILMINGTON, Del. - Impax Laboratories is enjoined from selling a generic version of the pain drug, Amrix, while Eurand and Anesta defend their patents on appeal, a federal judge ruled.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.